Skip to main content
Erschienen in: Der Internist 12/2012

01.12.2012 | CME Zertifizierte Fortbildung

Fieber ungeklärter Genese

Infektiöse Ursachen

verfasst von: Prof. Dr. B. Salzberger, A. Schneidewind, F. Hanses, G. Birkenfeld, M. Müller-Schilling

Erschienen in: Die Innere Medizin | Ausgabe 12/2012

Einloggen, um Zugang zu erhalten

Zusammenfassung

Infektionen sind mit einem Anteil von etwa 30% eine der häufigsten Ursachen eines ungeklärten Fiebers. Das Spektrum der Infektionen hängt von der klinischen Situation bzw. vom Risikoprofil des Patienten ab und variiert hinsichtlich der Kategorien des „klassischen“ Fiebers ungeklärter Genese und des ungeklärten Fiebers bei HIV-Infektion, bei immunsupprimierten Patienten und bei nosokomialem Fieber. Die wichtigste Frage ist, welche Eigenschaften von Erreger und Wirt eine spezifische Infektion zur Ursache eines ungeklärten Fiebers machen können.
Literatur
1.
Zurück zum Zitat Petersdorf RG, Beeson PB (1961) Fever of unexplained origin: report on 100 cases. Medicine 40:1–30PubMedCrossRef Petersdorf RG, Beeson PB (1961) Fever of unexplained origin: report on 100 cases. Medicine 40:1–30PubMedCrossRef
2.
Zurück zum Zitat Knockaert DC, Vanderschueren S, Blockmans D (2003) An evidence-based approach to fever of unknown origin. Arch Intern Med 163:1976–1977 (Autorenantwort: 1977–1978) Knockaert DC, Vanderschueren S, Blockmans D (2003) An evidence-based approach to fever of unknown origin. Arch Intern Med 163:1976–1977 (Autorenantwort: 1977–1978)
3.
Zurück zum Zitat Mourad O, Palda V, Detsky AS (2003) A comprehensive evidence-based approach to fever of unknown origin. Arch Intern Med 163:545–551PubMedCrossRef Mourad O, Palda V, Detsky AS (2003) A comprehensive evidence-based approach to fever of unknown origin. Arch Intern Med 163:545–551PubMedCrossRef
4.
Zurück zum Zitat Mackowiak PA, Durack DT (2010) Fever of unknown origin. In: Mandell GL, Bennett JE, Dolin R (Hrsg) (2010) Mandell, Douglas and Bennett’s principles and practices of infectious diseases. Elsevier, Philadelphia, S 779–790 Mackowiak PA, Durack DT (2010) Fever of unknown origin. In: Mandell GL, Bennett JE, Dolin R (Hrsg) (2010) Mandell, Douglas and Bennett’s principles and practices of infectious diseases. Elsevier, Philadelphia, S 779–790
5.
Zurück zum Zitat Al-Tonbary YA, Soliman OE, Sarhan MM et al (2011) Nosocomial infections and fever of unknown origin in pediatric hematology/oncology unit: a retrospective annual study. World J Pediatr 7:60–64PubMedCrossRef Al-Tonbary YA, Soliman OE, Sarhan MM et al (2011) Nosocomial infections and fever of unknown origin in pediatric hematology/oncology unit: a retrospective annual study. World J Pediatr 7:60–64PubMedCrossRef
6.
Zurück zum Zitat George DL, Falk PS, Umberto Meduri G et al (1998) Nosocomial sinusitis in patients in the medical intensive care unit: a prospective epidemiological study. Clin Infect Dis 27:463–470PubMedCrossRef George DL, Falk PS, Umberto Meduri G et al (1998) Nosocomial sinusitis in patients in the medical intensive care unit: a prospective epidemiological study. Clin Infect Dis 27:463–470PubMedCrossRef
7.
Zurück zum Zitat Hayakawa K, Ramasamy B, Chandrasekar PH (2012) Fever of unknown origin: an evidence-based review. Am J Med Sci 344:301–316CrossRef Hayakawa K, Ramasamy B, Chandrasekar PH (2012) Fever of unknown origin: an evidence-based review. Am J Med Sci 344:301–316CrossRef
8.
Zurück zum Zitat Link H, Bohme A, Cornely OA et al (2003) Antimicrobial therapy of unexplained fever in neutropenic patients—guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO), Study Group Interventional Therapy of Unexplained Fever, Arbeitsgemeinschaft Supportivmassnahmen in der Onkologie (ASO) of the Deutsche Krebsgesellschaft (DKG-German Cancer Society). Ann Hematol 82(Suppl 2):S105–117PubMedCrossRef Link H, Bohme A, Cornely OA et al (2003) Antimicrobial therapy of unexplained fever in neutropenic patients—guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO), Study Group Interventional Therapy of Unexplained Fever, Arbeitsgemeinschaft Supportivmassnahmen in der Onkologie (ASO) of the Deutsche Krebsgesellschaft (DKG-German Cancer Society). Ann Hematol 82(Suppl 2):S105–117PubMedCrossRef
9.
Zurück zum Zitat Bouza E, Loeches B, Munoz P (2007) Fever of unknown origin in solid organ transplant recipients. Infect Dis Clin North Am 21:1033–1054PubMedCrossRef Bouza E, Loeches B, Munoz P (2007) Fever of unknown origin in solid organ transplant recipients. Infect Dis Clin North Am 21:1033–1054PubMedCrossRef
10.
Zurück zum Zitat Auner HW, Sill H, Mulabecirovic A et al (2002) Infectious complications after autologous hematopoietic stem cell transplantation: comparison of patients with acute myeloid leukemia, malignant lymphoma, and multiple myeloma. Ann Hematol 81:374–377PubMedCrossRef Auner HW, Sill H, Mulabecirovic A et al (2002) Infectious complications after autologous hematopoietic stem cell transplantation: comparison of patients with acute myeloid leukemia, malignant lymphoma, and multiple myeloma. Ann Hematol 81:374–377PubMedCrossRef
11.
Zurück zum Zitat Heussel CP, Kauczor HU, Heussel GE et al (1999) Pneumonia in febrile neutropenic patients and in bone marrow and blood stem-cell transplant recipients: use of high-resolution computed tomography. J Clin Oncol 17:796–805 Heussel CP, Kauczor HU, Heussel GE et al (1999) Pneumonia in febrile neutropenic patients and in bone marrow and blood stem-cell transplant recipients: use of high-resolution computed tomography. J Clin Oncol 17:796–805
12.
Zurück zum Zitat Bongartz T, Sutton AJ, Sweeting MJ et al (2006) Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA 295:2275–2285PubMedCrossRef Bongartz T, Sutton AJ, Sweeting MJ et al (2006) Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA 295:2275–2285PubMedCrossRef
13.
Zurück zum Zitat Gluck T, Kiefmann B, Grohmann M et al (2005) Immune status and risk for infection in patients receiving chronic immunosuppressive therapy. J Rheumatol 32:1473–1480 Gluck T, Kiefmann B, Grohmann M et al (2005) Immune status and risk for infection in patients receiving chronic immunosuppressive therapy. J Rheumatol 32:1473–1480
14.
Zurück zum Zitat Armstrong WS, Katz JT, and Kazanjian PH (1999) Human immunodeficiency virus-associated fever of unknown origin: a study of 70 patients in the United States and review. Clin Infect Dis 28:341–345PubMedCrossRef Armstrong WS, Katz JT, and Kazanjian PH (1999) Human immunodeficiency virus-associated fever of unknown origin: a study of 70 patients in the United States and review. Clin Infect Dis 28:341–345PubMedCrossRef
15.
Zurück zum Zitat Kitkungvan D, Apisarnthanarak A, Plengpart P et al (2008) Fever of unknown origin in patients with HIV infection in Thailand: an observational study and review of the literature. Int J STD AIDS 19:232–235PubMedCrossRef Kitkungvan D, Apisarnthanarak A, Plengpart P et al (2008) Fever of unknown origin in patients with HIV infection in Thailand: an observational study and review of the literature. Int J STD AIDS 19:232–235PubMedCrossRef
16.
Zurück zum Zitat Abellan-Martinez J, Guerra-Vales JM, Fernandez-Cotarelo MJ et al (2009) Evolution of the incidence and aetiology of fever of unknown origin (FUO), and survival in HIV-infected patients after HAART (highly active antiretroviral therapy). Eur J Intern Med 20:474–477PubMedCrossRef Abellan-Martinez J, Guerra-Vales JM, Fernandez-Cotarelo MJ et al (2009) Evolution of the incidence and aetiology of fever of unknown origin (FUO), and survival in HIV-infected patients after HAART (highly active antiretroviral therapy). Eur J Intern Med 20:474–477PubMedCrossRef
17.
Zurück zum Zitat Letang E, Miro JM, Nhampossa T et al (2011) Incidence and predictors of immune reconstitution inflammatory syndrome in a rural area of Mozambique. PLoS One 6:e16946PubMedCrossRef Letang E, Miro JM, Nhampossa T et al (2011) Incidence and predictors of immune reconstitution inflammatory syndrome in a rural area of Mozambique. PLoS One 6:e16946PubMedCrossRef
18.
Zurück zum Zitat Muller M, Wandel S, Colebunders R et al (2010) Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis. Lancet Infect Dis 10:251–261PubMedCrossRef Muller M, Wandel S, Colebunders R et al (2010) Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis. Lancet Infect Dis 10:251–261PubMedCrossRef
19.
Zurück zum Zitat Novak RM, Richardson JT, Buchacz K et al (2012) Immune reconstitution inflammatory syndrome: incidence and implications for mortality. AIDS 26:721–730PubMedCrossRef Novak RM, Richardson JT, Buchacz K et al (2012) Immune reconstitution inflammatory syndrome: incidence and implications for mortality. AIDS 26:721–730PubMedCrossRef
20.
Zurück zum Zitat Dong MJ, Zhao K, Liu ZF et al (2011) A meta-analysis of the value of fluorodeoxyglucose-PET/PET-CT in the evaluation of fever of unknown origin. Eur J Radiol 80:834–844PubMedCrossRef Dong MJ, Zhao K, Liu ZF et al (2011) A meta-analysis of the value of fluorodeoxyglucose-PET/PET-CT in the evaluation of fever of unknown origin. Eur J Radiol 80:834–844PubMedCrossRef
Metadaten
Titel
Fieber ungeklärter Genese
Infektiöse Ursachen
verfasst von
Prof. Dr. B. Salzberger
A. Schneidewind
F. Hanses
G. Birkenfeld
M. Müller-Schilling
Publikationsdatum
01.12.2012
Verlag
Springer-Verlag
Erschienen in
Die Innere Medizin / Ausgabe 12/2012
Print ISSN: 2731-7080
Elektronische ISSN: 2731-7099
DOI
https://doi.org/10.1007/s00108-012-3173-8

Weitere Artikel der Ausgabe 12/2012

Der Internist 12/2012 Zur Ausgabe

Kongresse des BDI

BDI-Kongresse

Mitteilungen der DGIM

DGIM-Mitteilungen

Mitteilungen des BDI

Mitteilungen des BDI

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.